Atika Capital Management LLC
Position in DNTH — Dianthus Therapeutics, Inc. /DE/
CIK 1599731
NEW YORK, NY
Position in DNTH
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$10,808,895
+$5,264,998 QoQ
Shares Held
128,800
-4.3% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
1.77%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DNTH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Atika Capital Management LLC holds $86,900,565 across 13 Biotechnology names. DNTH ranks #4 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
300,000 | $15,815,999 | |
| 2 | COGT |
Cogent Biosciences, Inc.
|
293,200 | $11,285,267 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
229,900 | $11,276,594 | |
| 4 | DNTH |
Dianthus Therapeutics, Inc. /DE/
This page
|
128,800 | $10,808,895 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
62,100 | $6,545,339 | |
| 6 | IMNM |
Immunome Inc.
|
262,900 | $5,749,622 | |
| 7 | DBVT |
DBV Technologies S.A.
|
271,300 | $5,667,456 | |
| 8 | ASND |
Ascendis Pharma A/S
|
19,125 | $4,374,460 |
All Filings in DNTH
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,808,895 | 128,800 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $5,543,897 | 134,528 | Shares | Defined | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||